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Symposium
Biotechnology and International Law

Introduction
James P Chandler*
In the fall of 1999, McGeorge School of Law and the McGeorge Law Review
hosted the Symposium on Biotechnology and the Law, the first in a series of
symposia focusing on the numerous legal issues that concern the growing
biotechnology industry as well as larger issues relating to the impact of
biotechnology on the law and society.1 During the process of developing that
symposium, biotechnology attracted the attention of international legal scholars with
the negotiation of the Cartagena Protocol on Biosafety to the Convention on
Biological Diversity held in Montreal (Cartagena Protocol or Protocol). Prompted
by these events, Biotechnology and International Law naturally became the subject
for the McGeorge School of Law's 19th International Law Symposium. Because
biotechnology touches areas of law from broad ethical concerns to very specific and
technical intellectual property issues, we hope the articles included herein will be
only the first offerings of many.
The Symposium on Biotechnology and International Law was a condensed,
half-day affair that offered a surprisingly diverse range of viewpoints and subject
matter. The dominant topic was the then recently drafted Cartagena Protocol. As
conceived, the Protocol was to be the first multilateral instrument establishing
normative procedures that intended to prevent harm that could potentially be caused
by the release of bio-engineered species into the environment. Having survived a
rough history, the Protocol as drafted did not meet all expectations, but at least
represented the first binding multilateral agreement created under the Convention
on Biological Diversity. The following articles were presented at or inspired by the
Symposium on Biotechnology and International Law.
I would like first to note that we are pleased to include in this issue a Comment
by student Marc Victor in addition to the articles contributed under the auspices of
the Symposium. While not technically included as part of the symposium,
Mr. Victor's piece provides a backdrop for the symposium articles by giving a
nicely detailed history of the Cartagena Protocol and exploring some of the key
principles underlying the Protocol.
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Having represented DuPont at the Montreal negotiations of the Cartagena
Protocol, as well as many other international treaties and conventions, Thomas
Jacob offers a view of the Protocol from the perspective of the biotechnology
industry. Mr. Jacob provides a specific breakdown of the intended workings of the
Cartagena Protocol and touches on the relationship of the Protocol with other
international instruments. Mr. Jacob's article is particularly appreciated for
illuminating the motivations behind specific provisions of the Cartagena Protocol,
including an enlightening view of the actual negotiation and drafting procedures.
The article from Professor Stephen McCaffrey explores the Cartagena Protocol
in relation to general principles of international law that will effect its
implementation and interpretation. Presumably subject to established principles of
international law, the potential of the Protocol must be judged according to those
established principles. As noted in Mr. Jacob's article, the Protocol was not drafted
in a void of international law. As a distinguished scholar in the area of international
law, Professor McCaffrey is well suited to examine the Protocol in the context of
general international law principles.
Professor John Ntambirweki addresses the conflicts created between developed
and developing nations with regards to biotechnology. Confronted by directly
competing interests, the interest of a developing nation to profit from the use of its
natural resources competing with the interest of technologically developed nations
to have access to biological resources at low cost, international law appears to be
faced with choosing one side to the detriment of the other. Which interest should be
given priority, or can an acceptable compromise be found? Professor Ntambirweki
poses and explores the question of how the principle of sovereignty of a nation over
its natural resources can be reconciled with the idea that knowledge about biological
resources belongs to all.
Ambassador Alberto Sz6kely, as a longstanding advocate for environmental
protection, brings a critical view of the Protocol and the indications it gives
regarding the state of international environmental law. Contrary to the hopes and
expectations many had for the Cartagena Protocol, by drastically altering basic
concepts of sovereignty and the precautionary principle, the Protocol signifies the
triumph of economic and industrial concerns over those of environmental protection.
The Protocol essentially failed to live up to expectations in that its application is
very limited and its procedures inapplicable in many contexts.
Contributions to the Symposium that are not represented in these articles
included presentations on the United States Government's view on the subject of
biotechnology regulation; the position of Non-Governmental Organizations,
particularly those concerned with environmental protection;
and the principles of
2
Biology and the Law as they relate to biotechnology.
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See Raymond R. Coletta, Biotechnology and the Creationof Ethics, 32 McGEORGEL. REV. 89(2001).

